The CAC score and the power of zero: the heart test that measures the disease, not the risk

A CAC score counts the calcified plaque in your heart's arteries. It comes from a quick, low-dose CT scan, no contrast dye needed, and you walk out with one number: the Agatston score (named after the doctor who came up with the scoring method back in 1990 ^[14]). Of all the tests in prevention cardiology, this one gets you closest to looking the disease straight in the eye.

Why does that matter so much? Most heart tests measure a risk factor: your cholesterol, your blood pressure, your age. A CAC scan measures the plaque actually sitting in your arteries right now. You are not estimating the odds. You are counting the damage.

The results come in bands: 0, then 1 to 99, 100 to 299, 300 and up, with a separate tier for 1000 and above. Zero is the band everyone hopes for.

So what does a zero get you? A long warranty. In the MESA study, researchers tracked 3,116 people who started at a CAC of 0 ^[1]. The "warranty period" on that zero (basically how long you can expect to stay at very low risk of a heart event) ran roughly 3 to 7 years, depending on sex and ethnicity. Even a full decade later, only about 8 percent had climbed past a CAC of 100. When you start from nothing, plaque builds slowly.

That is the power of zero. A CAC of 0 is one of the strongest "negative risk markers" in all of cardiology ^[10], meaning a result that genuinely pushes your risk down rather than just failing to find a problem. It drops your short-to-mid-term risk hard. And it means a rescan every 3 to 7 years beats anxious yearly testing.

One honest caveat before we go on. A zero is not the same as zero risk. It tells you calcified plaque is absent today, not that nothing can ever go wrong. Soft plaque, smoking, diabetes: none of those show up in this number. We will get to all of it. For now, the headline holds. This is one of the best-evidenced longevity tests you can take that does not involve a supplement, because it measures the disease itself.

A high CAC score pushes your risk sharply upward, and it changes the whole statin conversation. The bigger the number, the louder the alarm.

Take the extreme end first. In MESA, 257 people landed at a CAC of 1000 or higher. Compared to people at zero, and even after the math accounts for the usual risk factors, their risk of any cardiovascular disease ran 4.71 times higher. Their risk of coronary heart disease (clogged arteries feeding the heart itself) ran 7.57 times higher. They had 3.4 events per 100 person-years ^[2]. Put plainly, that is about the same risk as someone who has already survived a heart attack and is now on full preventive treatment. A quiet scan can drop you into that category before a single symptom shows up.

Doctors generally call a score elevated once it climbs above 100 Agatston units, or above the 75th percentile for your age and sex.

Here is the part that actually flips decisions. Statins pay off most where the calcium already is. MESA put a number on it. The 10-year "number-needed-to-treat" (how many people you have to put on the drug to prevent one heart event) was about 87 when CAC was 0, but only about 24 when CAC was above 100. Same pill, wildly different payoff ^[4]. And here is the twist: among the people the guidelines actually recommended a statin for, 41 percent had a CAC of 0, with just 5.2 events per 1,000 person-years ^[3]. Broaden it to everyone a statin was recommended or considered for, and 44 percent had a CAC of 0, with 4.2 events per 1,000 person-years ^[3]. For a lot of them, the scan said "you are low risk after all."

The guidelines have caught up to this. The 2018 American cholesterol guideline (ACC/AHA) rates CAC a Class IIa tool, a solid yes, and openly backs holding off on a statin when CAC is 0, for adults aged 40 to 75 with an LDL cholesterol between 70 and 189 mg/dL. The exceptions: people with diabetes, current smokers, and anyone with a family history of early heart disease ^[5]. Europe's ESC 2021 guideline rates CAC a notch lower, Class IIb, useful for nudging risk up or down near the treatment line ^[6]. And Germany's own Heinz Nixdorf Recall study found that CAC sharpens risk assessment beyond what both the European and American guidelines pick up on their own ^[12].

A CAC scan is a tie-breaker, not a routine check-up. The sweet spot is narrow: an adult with no symptoms, roughly 40 to 70 years old, sitting at borderline or intermediate heart risk, stuck on a genuinely tough call about whether to start a statin. That is where the scan earns its keep.

What counts as intermediate risk? Usually a 10-year risk of heart disease somewhere around 5 to 20 percent. If you are in that zone and you and your doctor honestly cannot decide whether to start a statin, a CAC scan can break the tie. The ACC/AHA 2018 guideline treats this exact moment as Class IIa shared decision-making, meaning a reasonable thing to do together ^[5].

Now the honest part. This is not a test for everyone, and a good doctor will talk some people out of it:

• Already high-risk? You should be on treatment no matter what the score says, so the scan rarely changes the plan.
• Genuinely low-risk and young? Your odds of a problem are already so small that a scan mostly buys you a bill and a little radiation, with no decision riding on it.
• Having symptoms like chest pain or breathlessness? A CAC score is the wrong tool. You need a CT angiography or a stress test, which hunt for actual blockages and starved blood flow, not just calcium.

There are also a few exceptions that override even a perfect zero. People with diabetes, current smokers, and anyone with a strong family history of early heart disease are specifically left out of the "hold the statin" rule, even at CAC 0 ^[5]. Why? Because those drivers keep churning out events whether or not calcium has shown up yet. A diabetic smoker with a zero score is not off the hook.

So the rule of thumb is simple. If your treatment decision is already made, skip it. If you are stuck in the middle and want data that mirrors your actual arteries, a CAC scan is one of the most useful 20-minute investments you can make.

A CAC scan is a quick, no-contrast cardiac CT that takes minutes and delivers a low radiation dose, around 1 mSv on modern prospectively-gated scanners ^[13], roughly the natural background radiation you absorb over a few months. You lie still, electrodes time the images to your heartbeat, and a computer outputs your Agatston score.

The scan itself is almost boring, which is exactly what you want. You lie down, a few electrodes go on your chest, the CT scanner snaps images timed to your heartbeat, and the whole thing is done in minutes. No iodine dye is needed for the scoring, so no IV and nothing to worry about on the allergy front. A computer crunches the images into your Agatston score.

The question everyone actually asks is about the radiation, so here are the numbers. The dose is low. On modern protocols where the scanner only fires during a slice of your heartbeat (the technical name is prospectively-gated), it runs around 1 mSv, with older machines running higher. In the MESA cohort, one analysis clocked an average of about 1.05 mSv ^[13]. An older, broader survey found a wider range of 0.8 to 10.5 mSv across different protocols, with a median around 2.3 mSv ^[7]. That big spread came from old machines and settings. Newer scanners sit at the low end.

To put it in perspective: that low end is roughly the natural background radiation you soak up over a few months just by living on Earth. Low, but not nothing.

So here is the practical takeaway on repeat scans. A zero comes with a 3 to 7 year warranty ^[1], which means there is no reason to rescan every year. Yearly imaging just piles on radiation for no new information, because plaque barely budges on that timescale once you start at zero. Space your scans out.

One last thing worth knowing. Agatston scores are reliable, but at very low values they wobble a bit from scan to scan. So do not lose any sleep over a literal "1 versus 0" difference. What matters clinically is the gap between a clean zero and a clearly positive score, not the gap between a 0 and a barely-there 1. Treat the very low end as a fuzzy zone, not a hard line.

In Germany, if you have no symptoms, you pay for a CAC scan out of your own pocket. It counts as an IGeL service (Individuelle Gesundheitsleistung, basically a self-pay extra), not something the public insurance (GKV) covers. Budget roughly 150 to 400 EUR. Some clinics quote as little as 150 EUR, others charge up to about 500 EUR, depending on the practice and the city.

Why is it not covered? It comes down to one word: symptoms. In early 2024 the G-BA (the body that decides what German statutory insurance pays for) ruled that a heart CT clearly helps patients with a suspected chronic coronary heart disease, and from 2025 doctors can bill it as a covered service. But the same ruling refused to approve it as a screening test for people with no symptoms. So if you just want a CAC scan to check your risk while feeling fine, you are outside what insurance will pay back. The IGeL-Monitor, run by the Medizinischer Dienst, takes a critical view of these screening CTs, which is good to know before you book.

Austria and Switzerland work the same way. Without a clear symptom-driven reason, a calcium scan is usually a private, pay-it-yourself workup. In Austria that often means going to a Wahlarzt (a doctor who works outside the public contract system) and paying directly. In Switzerland you are typically covering it yourself in CHF unless there is a covered medical reason.

So what should steer the decision in the DACH region, when you are the one paying? For doctors here, the European reference point is the ESC 2021 prevention guideline, which rates CAC a Class IIb risk modifier near the treatment threshold ^[6]. Translation: it is a sensible add-on for the intermediate-risk call, not a blanket recommendation for everybody.

The bottom line for your wallet: this is a few hundred euros or francs of your own money, best spent when you are honestly on the fence about a statin. If your decision is already clear either way, the money buys you reassurance at best and an unnecessary scan at worst. Treat it as a targeted spend, not another checkbox on an annual health menu.

Here is the one limit you really need to understand: a CAC scan only sees hardened, calcified plaque. Soft plaque, the younger and more rupture-prone kind that has not turned to chalk yet, is invisible to it. So a zero score can sit right next to real disease.

How often does that happen? In the SCOT-HEART trial, among 642 patients with symptoms who scored a CAC of 0, 16 percent still had soft, non-calcified plaque show up on a CT angiogram ^[8]. And that soft plaque is not harmless. When the soft, fatty kind made up more than 4 percent of the artery wall, it predicted a heart attack on its own, with 4.65 times the risk, beyond anything the calcium score or the narrowing alone could tell you ^[9]. The ICONIC trial spotted the same kind of dangerous plaque lurking behind a CAC of 0 ^[16].

One nuance that matters: this blind spot is biggest in people who already have symptoms or who are younger. A zero is at its most reassuring exactly where the scan is built to be used, in symptom-free, middle-aged screening. It gets shakier in people with symptoms or with very high Lp(a).

Which is where two blood tests come in that pair perfectly with CAC. CAC is the plaque you have already built. ApoB and Lp(a) are the lifelong drivers that build it. ApoB counts every artery-clogging cholesterol particle in your blood. Lp(a) (say it "L-P-little-a," a cholesterol particle you mostly inherit) is set close to birth, so you only need to measure it once in your life. A 2022 analysis showed Lp(a) and CAC each predict heart-disease risk on their own, in both MESA and the Dallas Heart Study ^[11]. Someone with sky-high Lp(a) can show a CAC of 0 today and still be heading for real trouble. The calcium just has not formed yet. The driver is already there.

One last bit of honesty. All these CAC numbers come from big long-running studies (MESA) and CT-imaging trials (SCOT-HEART), not from a trial that randomly assigned people to CAC-guided care versus usual care and counted heart attacks. So the evidence is about predicting and reclassifying risk. Strong, but a different flavor of strong. And a zero never erases smoking, diabetes, or high blood pressure as ongoing drivers.